Effects of nitrate and prophylactic aspirin on upper gastrointestinal bleeding: A retrospective case-control study

Journal of International Medical Research

Volumn 26, Issue 3, 1998, Pages 120-128

  Lanas, A ^a   Bajador, E ^b   Serrano, P ^a   Arroyo, M ^a   Fuentes, J ^b   Santolaria, S ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Aspirin; Gastrointestinal bleeding; Low dose aspirin; Nitrates; Non steroidal antii nflammatory drugs; Peptic ulcer

Indexed keywords

ACETYLSALICYLIC ACID; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; DIGESTIVE SYSTEM HEMORRHAGE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER PYLORI; HEMATEMESIS; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MELENA; MORTALITY; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SHOCK; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031902422     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059802600302     Document Type: Article

References (19)

1. Soll AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. UCLA Conference. Ann Intern Med 1991; 114: 307-319.
2. Lanas A, Sekar MC, Hirschowitz BI: Objective evidence of aspirin use in both ulcer and non-ulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992; 103: 862-869.
3. Lanas A, Serrano P, Bajador E, et al: Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology 1997; 112: 683-689.
4. Wilcox CM, Shalek KA, Cotsonis G: Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. Arch Intern Med 1994; 154: 42-46.
5. Mitchell JA, Akarasereenont P, Thienermann C, et al: Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cycloxygenase. Proc Natl Acad Sci USA 1993; 90: 11693-11697.
6. Wallace JL, Reuter B, Cicala C, et al: Novel nonsteroidal anti-inflammatory drug derivates with markedly reduced ulcerogenic properties in the rat. Gastroenterology 1994; 107: 173-179.
7. Elliot SN, McKnight W, Cirino G, Wallace JL. A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 1995; 109: 524-530.
8. Wallace JL: Nonsteroidal anti-inflammatory drugs and gastroenteropathy. Gastroenterology 1997; 112: 1000-1016.
9. Lopez-Belmonte J, Whittle BJR, Moncada S: The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol 1993; 108: 73-78.
10. Bello R, Canet A, Calatayud S, et al: Transdermal nitroglycerin prevents gastric damage induced by nonsteroidal-anti-inflammatory drugs and bile salts. Eur J Pharmacol 1995; 281: R3-R4.
11. Salvemini D, Currie MG, Mollace V: Nitric oxide-mediated cycloxygenase activation. J Clin Invest 1996; 97: 2562-2568.
12. Roccatello D, Mengozzi G, Ferro M, et al: Isosorbide 5 mononitrate administration increases nitric oxide blood levels and reduces proteinuria in IgA glomerulonephritis patients with abnormal urinary endothelium/cyclic GMP ration. Clin Nephrol 1995; 44: 163-169.
13. Weil J, Colin Jones D, Langman MJS, et al: Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-830.
14. Kaufman DW, Kelly JP, Sheehan JE, et al: Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485-494.
15. Silagy CA, McNeil JJ, Donnan GA, et al: Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther 1993; 54: 84-89.
16. Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after transient ischemic attack or minor ischemic stroke. N Engl J Med 1991; 325: 1261-1266.
17. Slattery J, Warlow CP, Shorrock CJ, Langman MJ. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin - analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995; 37: 509-511.
18. Stalnikowicz-Darvasi R: Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events: a critical analysis. J Clin Gastroenterol 1995; 21: 13-16.
19. Calatayud S, Diaz de Rojas F, Bello R, et al: Transdermal nitroglycerin prevents the decrease in gastric mucosal blood flow induced by NSAIDs. Gastroenterology 1997; 112: A81.